Following the release and implementation of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6(R3) Good Clinical Practice (GCP) guidelines, Health Canada updated its guidance document (GUI-0100) to reflect the new requirements and provide greater clarity on their practical application.
In this session, Kevin Donato and Nilufer Hasanova from Health Canada’s Clinical Trials Compliance Program will review key updates to the guidance document, discuss practical compliance considerations, explain how GUI-0100 complements Part C, Division 5 of the Food and Drug Regulations and respond to questions.
In addition, Aleksandra Kuzmanovic, VCHRI quality lead, together with Zoe Glase and Jacquie Stevenson from the Vancouver Prostate Centre (VPC) will provide an overview of VCHRI-specific quality and compliance requirements and resources available to support researchers, including Standard Operating Procedures (SOPs), risk management tools and quality management processes. They will also share key learnings from a recent Health Canada site visit at VPC and highlight how quality management resources can support compliance and continuous improvement in clinical trials.
Learning objectives
In this session, you will learn how to:
- Navigate the key changes introduced in ICH E6(R3) and Health Canada's updated GUI-0100 guidance.
- Apply the principles outlined in GUI-0100 to support compliance with regulatory requirements and GCP.
- Recognize VCHRI-specific quality and compliance expectations.
- Identify opportunities to strengthen compliance and inspection preparedness.
About the speakers





This workshop is part of our VCHRI Research Training Series. This series is designed to support the acquisition of advanced skills, techniques and knowledge and lead to enhanced practices in the conduct of research.
Please note that all VCHRI Research Training session are recorded unless otherwise stated.